Patents by Inventor William Higuchi

William Higuchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Non-invasive ocular drug delivery
    Patent number: 7785578
    Abstract: The present invention is drawn to a pharmaceutical compound for the treatment of posterior retinal diseases through topical application of the compound. The compound includes an effective amount of a therapeutic compound, and at least one additional agent that helps to prolong the residence time of the therapeutic compound within the extraocular space, or increase the transport of the therapeutic compound across a tissue of an eye toward and into a posterior ocular region, or both. The invention is additionally drawn to a device and method for delivering the compound.
    Type: Grant
    Filed: October 11, 2002
    Date of Patent: August 31, 2010
    Assignee: Aciont, Inc.
    Inventors: David J. Miller, S. Kevin Li, William Higuchi
  • Methods and devices for sustained in-vivo release of an active agent
    Publication number: 20060089590
    Abstract: The present invention includes methods and devices for providing sustained in-vivo release of an active agent to a subject. In some aspects, such release may be achieved by reacting an active agent in-vivo with a depot forming agent in order to form a sustained release active agent depot inside the subject. The depot can then release the active agent over a sustained period of time.
    Type: Application
    Filed: September 27, 2005
    Publication date: April 27, 2006
    Inventors: John Higuchi, S. Li, William Higuchi, Daniel Mufson, Michael Delmage, Anthony Tuitupou, Rajan Koehambilli
  • Methods and devices for sustained in-vivo release of an active agent
    Publication number: 20060088515
    Abstract: The present invention includes methods and devices for providing sustained in-vivo release of an active agent to a subject. In some aspects, such release may be achieved by reacting an active agent in-vivo with a depot forming agent in order to form a sustained release active agent depot inside the subject. The depot can then release the active agent over a sustained period of time.
    Type: Application
    Filed: September 27, 2005
    Publication date: April 27, 2006
    Inventors: John Higuchi, S. Li, William Higuchi, Matthew Hastings
  • Non-invasive ocular drug delivery
    Publication number: 20040071761
    Abstract: The present invention is drawn to a pharmaceutical compound for the treatment of posterior retinal diseases through topical application of the compound. The compound includes an effective amount of a therapeutic compound, and at least one additional agent that helps to prolong the residence time of the therapeutic compound within the extraocular space, or increase the transport of the therapeutic compound across a tissue of an eye toward and into a posterior ocular region, or both. The invention is additionally drawn to a device and method for delivering the compound.
    Type: Application
    Filed: October 11, 2002
    Publication date: April 15, 2004
    Inventors: David J. Miller, S. Kevin Li, William Higuchi